| 14-May-13 07:07AM | Q1 2013 OPEXA THERAPEUTICS INC Earnings Release - Before Market Open CCBN -16.97% |
| 06:00AM | Opexa Therapeutics Reports First Quarter 2013 Financial Results and Provides Corporate Update Business Wire |
| 13-May-13 11:07PM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, EDGAR Online +26.01% |
| 11:07PM | OPEXA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 10-May-13 09:00AM | Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss First Quarter 2013 Financial Results Business Wire |
| 11-Apr-13 08:36AM | The Vatican's Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Host 2nd International Vatican Adult Stem Cell Conference GlobeNewswire |
| 04-Apr-13 01:04PM | OPEXA THERAPEUTICS, INC. Financials EDGAR Online Financials |
| 08:30AM | Opexa Therapeutics to Present at the Regenerative Medicine - A Fundamental Shift in Science & Culture Conference Business Wire |
| 01-Apr-13 09:03AM | InPlay: Opexa Therapeutics announces that Karthik Radhakrishnan has been appointed Chief Financial Officer Briefing.com -5.56% |
| 09:00AM | Opexa Therapeutics Announces Changes to Senior Management Team Business Wire |
| 02:19AM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial State EDGAR Online |
| 29-Mar-13 02:15AM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online |
| 28-Mar-13 07:00PM | Opexa Therapeutics Reports Year End 2012 Financial Results and Provides Corporate Update Business Wire |
| 26-Mar-13 09:02PM | Chelsea Therapeutics: A Shoe-In For FDA Approval, Shares Could Double From Here at Seeking Alpha +23.70% |
| 09:01AM | Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors at Seeking Alpha |
| 22-Mar-13 08:57AM | The Vatican's Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Announce Highlights of the Upcoming Second International Adult Stem Cell Conference GlobeNewswire |
| 12-Mar-13 10:39AM | Opexa Therapeutics Poised For Breakout at Seeking Alpha +14.58% |
| 04-Mar-13 08:00AM | Opexa Therapeutics to Present at the 6th Annual European Life Science CEO Forum Business Wire |
| 27-Feb-13 12:06PM | Opexa granted extension to meet Nasdaq equity requirements at bizjournals.com |
| 08:32AM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online |
| 23-Feb-13 01:04PM | OPEXA THERAPEUTICS, INC. Financials EDGAR Online Financials |
| 14-Feb-13 02:22PM | Opexa Therapeutics Gets Attention From Institutions, Should It Get Yours? at Seeking Alpha +5.13% |
| 12-Feb-13 08:27AM | InPlay: Opexa Therapeutics: Sabby Management disclosed 9.58% passive stake in 13G filing out last night Briefing.com |
| 11-Feb-13 05:15PM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +6.28% |
| 08:31AM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online |
| 07-Feb-13 09:06AM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stat EDGAR Online -9.18% |
| 09:06AM | Opexa Therapeutics announces common stock and warrant offering theflyonthewall.com |
| 09:06AM | InPlay: Opexa Therapeutics prices offering of shares of its common stock and warrants to purchase common stock in a private registered offering of 1,083,334 units at $3.00 per unit Briefing.com |
| 09:00AM | Opexa Therapeutics, Inc. Announces Pricing of Common Stock and Warrant Offering Business Wire |
| 08:30AM | Opexa Therapeutics to Present at the 15th Annual BIO CEO & Investor Conference Business Wire |
| 06-Feb-13 09:31AM | Opexa Collaborates with Merck Serono and 4 Stocks at 52-Week Highs at Wall St. Cheat Sheet -6.67% |
| 08:20AM | Biotech Companies Attractive Targets for Pharmaceutical Companies Looking to Replace Lost Revenues Marketwire |
| 08:16AM | Opexa Rallies Bigtime On Deal With Merck Serono at Seeking Alpha |
| 05-Feb-13 01:13PM | Opexa, Merck deal good step forward, analyst says at bizjournals.com +160.33% |
| 12:30PM | Stocks Rebound Sharply; Nasdaq Jumps 1% at TheStreet |
| 11:42AM | Stocks Rebound Sharply; Nasdaq Jumps 1% at TheStreet |
| 10:05AM | Investors Overreact to Opexa Finding Scant Interest for Failed Multiple Sclerosis Drug at TheStreet |
| 09:59AM | Stocks Rebound From Monday's Steep Retreat at TheStreet |
| 09:11AM | Stocks to Watch: Yum Brands, Idenix Pharma, Opexa Therapeutics at The Wall Street Journal |
| 07:38AM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stat EDGAR Online |
| 07:31AM | InPlay: Opexa Therapeutics and Merck Serono (MKGAY) enter into option and license agreement for development of Tcelna (imilecleucel-T) for treatment of multiple sclerosis Briefing.com |
| 07:30AM | Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna (imilecleucel-T) for Treatment of Multiple Sclerosis Business Wire |
| 30-Jan-13 05:17PM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity EDGAR Online |
| 25-Jan-13 04:46PM | Opexa closes private offering with $650,000 raised at bizjournals.com +5.83% |
| 23-Jan-13 05:17PM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financi EDGAR Online |
| 05:15PM | Opexa Therapeutics Closes Private Note Offering Business Wire |
| 15-Jan-13 10:30AM | Opexa regains compliance with Nasdaq price listing at bizjournals.com |
| 08:36AM | Opexa Therapeutics regains compliance with Nasdaq bid price listing requirement theflyonthewall.com |
| 08:31AM | InPlay: Opexa Therapeutics regains compliance with NASDAQ minimum bid price listing requirement Briefing.com |
| 08:30AM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 08:30AM | Opexa Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement Business Wire |
| 17-Dec-12 03:51PM | Opexa stock down amid news of reverse stock split at bizjournals.com -18.60% |
| 14-Dec-12 04:07PM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to Artic EDGAR Online |
| 30-Nov-12 04:31PM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St EDGAR Online |
| 22-Nov-12 01:05PM | OPEXA THERAPEUTICS, INC. Financials EDGAR Online Financials |
| 21-Nov-12 11:58AM | Opexa Therapeutics to raise $16.5M at bizjournals.com |
| 20-Nov-12 04:15PM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online -6.38% |
| 15-Nov-12 07:07AM | Q3 2012 OPEXA THERAPEUTICS INC Earnings Release - Before Market Open CCBN -6.25% |
| 14-Nov-12 08:06AM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online |
| 08:03AM | OPEXA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 08:00AM | Opexa Therapeutics Reports Third Quarter 2012 Financial Results and Provides Corporate Update Business Wire |
| 13-Nov-12 08:33AM | InPlay: Opexa Therapeutics receives clinical trial approval from Health Canada for Novel T-Cell therapy Briefing.com |
| 08:32AM | Opexa Therapeutics receives clincial trial approval for novel T-cell therapy theflyonthewall.com |
| 08:30AM | Opexa Receives Clinical Trial Approval From Health Canada for Novel T-Cell Therapy Business Wire |
| 12-Nov-12 03:05PM | Opexa Therapeutics to Present at the Lazard Capital Markets 9th Annual Healthcare Conference Business Wire |
| 05-Nov-12 05:24PM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity EDGAR Online |
| 05:20PM | Opexa Announces Agreements for up to $16.5 Million in Equity Commitments Business Wire |
| 12-Oct-12 01:04PM | 5 Stocks Poised for Breakouts at TheStreet |
| 02-Oct-12 09:17AM | Lessons From Biotech's Best Third Quarter Stocks at TheStreet |
| 08:31AM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online |
| 17-Sep-12 03:15PM | Opexa to Participate at UBS Global Life Sciences Conference Business Wire |
| 14-Sep-12 04:20AM | Biotechs Treating Incurable Disease Warrant Early Look at Seeking Alpha -5.19% |
| 13-Sep-12 12:01PM | Apple CHANGES UP Charger and 4 Hot Stocks Sparking Chatter at Wall St. Cheat Sheet |
| 08:31AM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online |
| 12-Sep-12 10:53AM | PropThink: Weakened OPXA Gets a Needed Boost with Initiation of Phase IIb Trial Thomson Reuters ONE +8.70% |
| 07:10AM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online |
| 07:08AM | Opexa Therapeutics begin Phase IIb clinical trial of Tcelna for sclerosis at theflyonthewall.com |
| 07:05AM | Opexa Initiates Late Stage Clinical Study of Tcelna in Patients with Secondary Progressive Multiple Sclerosis (SPMS) Business Wire |
| 10-Sep-12 07:30AM | Opexa to Participate at Upcoming Industry Conferences Business Wire +10.77% |
| 09-Sep-12 03:50PM | Healthcare Business Replay: Peregrine Shares SHOOT The Moon, Opexas New AGREEMENT at Wall St. Cheat Sheet |
| 07-Sep-12 05:48PM | Healthcare Business Replay: Peregrine Shares SHOOT The Moon, Opexas New AGREEMENT at Wall St. Cheat Sheet |
| 08:31AM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh EDGAR Online |
| 05-Sep-12 07:05PM | Gov. Perry appoints two Houston-area execs to ETF committee at bizjournals.com -7.14% |
| 07:05PM | Gov. Perry appoints two Houston-area execs to ETF committee at bizjournals.com |
| 06:45PM | Gov. Perry appoints two Houston-area execs to ETF committee at bizjournals.com |
| 18-Aug-12 01:04PM | OPEXA THERAPEUTICS, INC. Financials EDGAR Online Financials |
| 13-Aug-12 08:31AM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Notice of Delisting or Fa EDGAR Online -11.32% |
| 08:30AM | Opexa Therapeutics Reports Second Quarter 2012 Financial Results and Provides Corporate Update Business Wire |
| 26-Jul-12 08:32AM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financi EDGAR Online |
| 08:30AM | Opexa Therapeutics Closes Secured Note Financing Business Wire |
| 17-Jul-12 04:40PM | 3 Pharmaceutical Stocks Making Big Moves at Seeking Alpha |
| 16-Jul-12 11:31AM | Conmed Healthcare Management, Zogenix Among Stocks Gapping Up Monday at Fox Business -7.25% |
| 10:59AM | Conmed Healthcare Management, Zogenix Among Stocks Gapping Up Monday at Fox Business |
| 11-Jul-12 12:19PM | 4 Small-Cap Pharma Stocks With Zero Debt To Consider Currently at Seeking Alpha |
| 29-Jun-12 05:31PM | Amtech Systems, Savient Pharmaceuticals Among Stocks falling to Annual Lows Friday at Fox Business -5.88% |
| 04:58PM | Amtech Systems, Savient Pharmaceuticals Among Stocks falling to Annual Lows Friday at Fox Business |
| 24-May-12 01:05PM | OPEXA THERAPEUTICS, INC. Financials EDGAR Online Financials |
| 21-May-12 08:30AM | Opexa Therapeutics Announces TcelnaTM as New Brand Name for MS Therapy Business Wire +6.38% |
| 11-May-12 08:32AM | OPEXA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online -6.45% |
| 08:30AM | Opexa Therapeutics Reports First Quarter 2012 Financial Results and Provides Corporate Update Business Wire |
